Tag: Novo

Novo Nordisk reported strong demand for its Wegovy pill, which launched in the U.S. in January, with about 50,000 prescriptions ...

The pharmaceutical sector is witnessing significant attention on GLP-1 weight-loss drugs, with Novo Nordisk (NYSE: NVO) initially leading the market. ...

A pill form of the weight-loss drug Wegovy, produced by Novo Nordisk, is now available in the U.S. at a ...

Shares of Novo Nordisk (NYSE: NVO) rose 3.5% on Monday, coinciding with gains in the S&P 500 and Nasdaq Composite. ...

Several applications for generic semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy, are currently under review by Health ...

Shares of Denmark's pharmaceutical company Novo Nordisk (NYSE: NVO) fell by 4% following the termination of its partnership with telehealth ...

Novo Nordisk has terminated its partnership with Hims & Hers Health due to allegations of the telehealth company selling counterfeit ...

Novo Nordisk (NVO -1.69%), known for its GLP-1 weight loss drugs Ozempic and Wegovy, saw a 2% decline after Reuters ...

Danish drugmaker Novo Nordisk presented its annual report in Bagsvaerd, Denmark, showcasing flags with the company's logos, including those of ...

Novo Nordisk defended disappointing trial results for its obesity drug candidate CagriSema, emphasizing its importance as a weight loss treatment ...